Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study - Concepedia

Concepedia

Publication | Closed Access

Pharmacotherapy vs. minimally invasive therapies as initial therapy for moderate-to-severe benign prostatic hyperplasia: a cost-effectiveness study

26

Citations

35

References

2022

Year

Yeva Sahakyan, Ayşegül Erman, Naeem Bhojani, Bilal Chughtai, Kevin C. Zorn, Beate Sander, Dean Elterman

Prostate Cancer and Prostatic Diseases

UrologyMedicineInvasive TherapiesBenign Prostatic HyperplasiaPharmacotherapyUrogynecologyProstatic DiseaseOncologyCost-effectiveness StudyInitial Therapy

References

	Year	Citations

Page 1